PTEN and acute lymphoblastic leukemia: PTEN is the main negative regulator of the PI3K-AKT pathway and its genetic lesions (mutations or deletions) trigger the hyperactivation of this oncogenic pathway in T-ALL due to the increase in AKT1 kinase activity [11].